Rindopepimut
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rindopepimut, covering 2017-10-18 to 2018-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme [Phase 2]